Shopping Cart
Total:
$0.00
Two out of every three people diagnosed with Alzheimer's disease are women. That statistic is not simply a reflection of the fact that women live longer. Growing research points to specific biological factors including hormonal shifts, neuroinflammatory vulnerability, and nutritional deficiencies that make women's brains distinctly more susceptible to cognitive decline with age.
One mineral is showing up repeatedly in the research: magnesium. And the science behind it is more specific, and more actionable, than most people realize.
Magnesium is naturally obtained through whole foods and water, originating from the mineral content of soil. But modern factors, like soil depletion, food processing, and increased physiological demand can make it harder to maintain optimal levels through diet alone.
A landmark 2023 study from the Australian National University, published in the European Journal of Nutrition, analyzed more than 6,000 cognitively healthy adults in the United Kingdom between the ages of 40 and 73. Using MRI brain imaging and detailed dietary tracking over 16 months, researchers found that people consuming more than 550 milligrams of magnesium per day had a brain age approximately one year younger by age 55 compared to those consuming the typical intake of around 350 milligrams.
A 41% increase in magnesium intake was associated with less age-related brain shrinkage and less brain shrinkage is directly associated with better cognitive function and lower dementia risk. The findings were more pronounced in women than in men, and more pronounced in post-menopausal women than pre-menopausal women.
The researchers concluded that higher magnesium intake from a younger age may help protect against neurodegenerative diseases and cognitive decline, well before symptoms appear.
Separately, a study following more than 1,000 middle-aged adults for 17 years found that those with the highest magnesium intake had a 37% lower risk of developing dementia compared to those with the lowest intake.
Nearly two-thirds of all Alzheimer's diagnoses occur in women, according to a 2025 review published in Frontiers in Molecular Biosciences. While longevity plays a role, the evidence increasingly points to hormonal biology as a key driver, specifically the loss of estrogen during and after menopause.
Estrogen is not just a reproductive hormone. It acts as a neuroprotector in the brain — supporting synaptic plasticity, mitochondrial function, and cerebrovascular integrity. When estrogen levels drop sharply at menopause, the brain loses one of its primary protective mechanisms at the same time that age-related risks begin to compound.
The Alzheimer's Society notes that post-menopausal women have lower levels of estrogen in their brains than men of the same age, because men continue converting testosterone to estrogen throughout their lives. This gap is believed to contribute meaningfully to women's elevated Alzheimer's risk.
Here is where magnesium becomes especially relevant for women: research published in PMC found that estrogen decline in ovariectomized animals causes both extracellular and intracellular magnesium deficiency, which in turn triggers neuroinflammation through the upregulation of inflammatory cytokines and microglial activation. Magnesium administration mitigated these effects. In other words, the hormonal changes of menopause may actively deplete brain magnesium, creating a two-part vulnerability that makes daily magnesium replenishment particularly important for women in midlife and beyond.
The research is clear that magnesium deficiency is associated with accelerated cognitive aging and higher dementia risk. What is less settled is whether supplementation alone — separate from dietary intake — is sufficient to reverse established disease.
A 2024 systematic review and meta-analysis covering cohort studies found consistent U-shaped associations between serum magnesium and all-cause dementia risk, with the lowest risk observed around a serum magnesium concentration of approximately 0.85 mmol/L. Both too low and too high appears to carry risk. The key is maintaining an optimal range consistently.
A comprehensive 2025 review in Nutrients covering magnesium's role in depression, migraine, Alzheimer's disease, and cognitive health concluded that maintaining adequate magnesium levels appears to be of preventive value, particularly in older adults and those with metabolic risk factors, due to its antioxidant, anti-inflammatory, and neuroprotective mechanisms.
Research has shown that individuals with Alzheimer’s disease tend to have lower magnesium levels in brain tissue compared to healthy controls, suggesting that magnesium deficiency may be part of the disease process itself, not just a contributing risk factor. Because of this, restoring magnesium levels is being explored as a potential therapeutic strategy. However, more clinical research is needed to determine the most effective timing, form, and dosage.
The current consensus: magnesium is not a cure, but consistent adequate intake, starting well before symptoms appear may be one of the most accessible and evidence-supported tools for protecting the aging brain.
Magnesium is not just an energy mineral. In the brain, it plays several distinct neuroprotective roles that are directly relevant to dementia prevention.
It regulates NMDA receptors — the receptors responsible for learning, memory, and synaptic plasticity. Magnesium acts as a natural blocker of these receptors, preventing overactivation. When NMDA receptors are over-stimulated, a process called excitotoxicity, neurons sustain damage and eventually die. Low magnesium removes this protective block, leaving neurons more vulnerable to excitotoxic death. Research published in Frontiers in Endocrinology confirms magnesium's essential role in managing NMDA receptor activity to prevent excitotoxicity.
It preserves blood-brain barrier integrity — the barrier that protects the brain from circulating toxins and inflammatory molecules. Research in PMC shows that magnesium deficiency contributes to blood-brain barrier disruption, which is a key pathway in neurodegeneration. Adequate magnesium helps maintain the structural integrity of this barrier.
It reduces neuroinflammation — the chronic low-grade inflammation in the brain that is a hallmark of neurodegenerative disease. Magnesium inhibits the activation of NF-κB, a master regulator of inflammatory responses, and reduces microglial neurotoxic activity. Magnesium deficiency, conversely, upregulates neuroinflammatory gene expression in the hippocampus and cortex, the brain regions most affected in early Alzheimer's.
It supports mitochondrial energy production — the cellular machinery that powers neurons. Healthy neurons are energy-intensive; when mitochondrial function declines, neurons become more vulnerable to stress and degeneration. Magnesium is essential to ATP production and to keeping cellular energy systems running efficiently.
Not all magnesium supplements reach the brain equally. Standard forms, magnesium oxide, magnesium citrate, are absorbed in the gut and raise serum magnesium, but have limited ability to cross the blood-brain barrier and influence brain tissue directly.
Research has identified magnesium L-threonate as the form most effective at raising brain magnesium specifically. A study cited in PMC noted that dietary intake of magnesium L-threonate could significantly increase magnesium levels in the brain compared to other magnesium compounds including magnesium chloride, magnesium citrate, and magnesium gluconate. A separate study in humans aged 18 to 65 found significant improvements in cognition in the group receiving magnesium L-threonate compared to placebo, particularly in older participants.
That said, the form most consistently supported across the broader clinical evidence for neurological health, including the migraine research is magnesium glycinate. It is highly bioavailable, well tolerated, and absorbs efficiently without the digestive side effects common to oxide and citrate forms. It raises both serum and tissue magnesium reliably, which matters for the nervous system regulation, sleep quality, and blood-brain barrier integrity that daily magnesium is meant to support.
The consistent thread in the evidence is this: daily, adequate magnesium maintained over time, not a short-term supplement course, is what the research associates with lower dementia risk and better brain aging outcomes. The 2023 ANU study found meaningful brain protection at intakes above 550 mg daily, notably higher than the standard dietary recommendation of around 310–420 mg. For anyone serious about long-term brain health, closing that gap consistently is where the work happens.
For people who experience migraines, the magnesium and brain aging picture is especially relevant. The same neuroinflammatory mechanisms that drive migraine risk also drive the conditions that increase dementia vulnerability: blood-brain barrier disruption, NMDA receptor overactivation, mitochondrial stress, and low-grade chronic inflammation.
The migraine brain's ion channel sensitivity means it is already operating with tighter neurological margins. Consistent daily magnesium is not just relevant to preventing attacks, it is part of supporting the long-term neurological environment that reduces cumulative brain aging risk.
The research consistently points in one direction: the protective effects of magnesium on brain aging are most significant when intake is adequate across decades, not introduced at the point of symptoms.
The 2023 ANU study measured brain effects in people aged 40 to 73, well before typical dementia onset. The researchers specifically highlighted that higher magnesium intake from a younger age may safeguard against neurodegenerative disease by the time the 40s and 50s arrive. For women, the menopausal transition, typically occurring in the late 40s to early 50s, represents a particularly critical window. Estrogen loss compounds magnesium depletion, inflammation rises, and the brain's protective environment shifts.
But here is what the research also shows: the brain is remarkably responsive to nutritional support at every stage. The 2023 ANU study included participants up to age 73, and higher magnesium intake was associated with better brain structure across the entire age range, not just in the youngest participants. The neuroprotective mechanisms magnesium engages, reducing neuroinflammation, blocking excitotoxicity, preserving blood-brain barrier integrity, supporting mitochondrial energy are active and relevant regardless of when you start.
There is currently no pharmaceutical cure for dementia. But the growing body of evidence on magnesium offers something genuinely encouraging: a safe, accessible, daily habit with a strong biological rationale and meaningful research support behind it. Whether you are in your 40s building a long-term foundation, or in your 60s and 70s looking to protect what you have, consistent daily magnesium is one of the most evidence-backed steps available. The best time to start was years ago. The second best time is now.
Our Magnesium is formulated for daily nervous system and brain support, without sweeteners, fillers, or unnecessary additives. We use forms with high bioavailability, and our products are recommended as part of daily mineral maintenance in migraine-focused nutrition protocols that prioritize neurological stability as a baseline, not a response to symptoms.
The goal of daily magnesium is not to treat dementia. It is to give the brain the consistent mineral environment it needs to age well from the inside out.
This content is for educational purposes and is not a substitute for medical advice. If you have concerns about cognitive health or dementia risk, please consult a qualified healthcare provider.
Sources
Alateeq, Walsh & Cherbuin — Dietary Magnesium Intake Is Related to Larger Brain Volumes and Lower White Matter Lesions With Notable Sex Differences. European Journal of Nutrition, 2023.
Medical News Today — Higher Magnesium Intake Linked to Better Brain Health. March 2023.
Harvard Health Publishing — Magnesium-Rich Foods Might Boost Brain Health, Especially in Women. September 2023.
ScienceDaily / Australian National University — A Higher Dose of Magnesium Each Day Keeps Dementia at Bay. March 2023.
PMC — Magnesium May Be an Effective Therapy for Alzheimer's Disease. 2022.
PMC — The Role of Magnesium in Depression, Migraine, Alzheimer's Disease, and Cognitive Health. Nutrients, 2025.
PMC — Magnesium and the Brain: A Focus on Neuroinflammation and Neurodegeneration. 2023.
Frontiers in Endocrinology — Neuroprotective Effects of Magnesium: Implications for Neuroinflammation and Cognitive Decline. 2024.
Magnesium and Cognitive Health in Adults: A Systematic Review and Meta-Analysis. ScienceDirect. 2024.
Frontiers in Molecular Biosciences — Estrogen, Menopause, and Alzheimer's Disease. 2025.
Alzheimer's Society — Hormones and Dementia Risk.
Alzheimer's Drug Discovery Foundation — Magnesium: Cognitive Vitality for Researchers.
